Brevan Howard Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,869
| Closed | -$502K | – | 1911 |
|
|
2025
Q1 | $502K | Buy |
7,869
+2,884
| +58% | +$184K | ﹤0.01% | 684 |
|
|
2024
Q4 | $606K | Buy |
4,985
+1,339
| +37% | +$163K | ﹤0.01% | 534 |
|
|
2024
Q3 | $455K | Sell |
3,646
-431
| -11% | -$53.8K | ﹤0.01% | 652 |
|
|
2024
Q2 | $644K | Sell |
4,077
-6,635
| -62% | -$1.05M | 0.01% | 477 |
|
|
2024
Q1 | $1.39M | Buy |
10,712
+2,653
| +33% | +$343K | 0.01% | 153 |
|
|
2023
Q4 | $777K | Buy |
8,059
+6,184
| +330% | +$596K | 0.01% | 271 |
|
|
2023
Q3 | $227K | Buy |
+1,875
| New | +$227K | ﹤0.01% | 245 |
|